ArticleJournal of Cancer2021

Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy.

Martin Svaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.